Toronto Dominion Bank’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-6
Closed 1347
2022
Q1
$0 Hold
6
﹤0.01% 1432
2021
Q4
$0 Buy
+6
New +$194 ﹤0.01% 1520
2017
Q2
Sell
-1
Closed 1207
2017
Q1
$0 Sell
1
-50
-98% -$1.95K ﹤0.01% 1198
2016
Q4
$2K Hold
51
﹤0.01% 1166
2016
Q3
$2K Sell
51
-159
-76% -$5.57K ﹤0.01% 1163
2016
Q2
$7K Hold
210
﹤0.01% 1123
2016
Q1
$6K Hold
210
﹤0.01% 1139
2015
Q4
$7K Hold
210
﹤0.01% 989
2015
Q3
$6K Sell
210
-17
-7% -$593 ﹤0.01% 985
2015
Q2
$9K Sell
227
-25
-10% -$1.12K ﹤0.01% 1014
2015
Q1
$12K Sell
252
-155
-38% -$7.18K ﹤0.01% 991
2014
Q4
$18K Buy
+407
New +$16K ﹤0.01% 957

Other funds holding AVNS

Toronto Dominion Bank's AVNS Position: Q2 2022 in Review

Toronto Dominion Bank sold out of Avanos Medical (AVNS) in Q2 2022, closing a stake of 6 shares.

Toronto Dominion Bank first reported a position in AVNS in Q4 2014 and held it in 12 quarters. The position peaked at $18K in Q4 2014. 287 funds tracked by Wall St. Rank hold AVNS as of Q2 2022.

  • Toronto Dominion Bank reported no remaining Avanos Medical position as of Q2 2022 after selling out during the quarter.
  • Toronto Dominion Bank sold 6 Avanos Medical shares in Q2 2022.
  • Toronto Dominion Bank first reported a position in Avanos Medical in Q4 2014 and held it in 12 quarters.
  • Toronto Dominion Bank's Avanos Medical position peaked at $18K in Q4 2014.
  • 287 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2022.

Based on Toronto Dominion Bank's 13F filing for Q2 2022, filed 11 Aug 2022.